OGDHL
2-oxoglutarate dehydrogenase-like, mitochondrial
Also known as: FLJ10851, OGDHL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULD0
- Gene
- OGDHL
- Ensembl
- ENSG00000197444
- Chromosome
- 10
- Canonical length
- 1010 aa
- Protein class
- Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoli fibrillar center
OverviewNCBI Gene
The protein encoded by this gene is similar to oxoglutarate dehydrogenase (OGDH) of the OGDH complex, which degrades glucose and glutamate. This gene encodes several isoforms, including some that appear to localize to mitochondria. The encoded protein down-regulates the AKT signaling cascade and can suppress the growth of cervical cancer cells. [provided by RefSeq, Dec 2016]
Canonical amino-acid sequenceUniProt
1010 residues, UniProt reviewed canonical sequence.
>Q9ULD0|OGDHL
1 MSQLRLLPSR LGVQAARLLA AHDVPVFGWR SRSSGPPATF PSSKGGGGSS YMEEMYFAWL
61 ENPQSVHKSW DSFFREASEE AFSGSAQPRP PSVVHESRSA VSSRTKTSKL VEDHLAVQSL
121 IRAYQIRGHH VAQLDPLGIL DADLDSFVPS DLITTIDKLA FYDLQEADLD KEFQLPTTTF
181 IGGSENTLSL REIIRRLENT YCQHIGLEFM FINDVEQCQW IRQKFETPGV MQFSSEEKRT
241 LLARLVRSMR FEDFLARKWS SEKRFGLEGC EVMIPALKTI IDKSSEMGIE NVILGMPHRG
301 RLNVLANVIR KDLEQIFCQF DPKLEAADEG SGDVKYHLGM YHERINRVTN RNITLSLVAN
361 PSHLEAVDPV VQGKTKAEQF YRGDAQGKKV MSILVHGDAA FAGQGVVYET FHLSDLPSYT
421 TNGTVHVVVN NQIGFTTDPR MARSSPYPTD VARVVNAPIF HVNADDPEAV IYVCSVAAEW
481 RNTFNKDVVV DLVCYRRRGH NEMDEPMFTQ PLMYKQIHRQ VPVLKKYADK LIAEGTVTLQ
541 EFEEEIAKYD RICEEAYGRS KDKKILHIKH WLDSPWPGFF NVDGEPKSMT CPATGIPEDM
601 LTHIGSVASS VPLEDFKIHT GLSRILRGRA DMTKNRTVDW ALAEYMAFGS LLKEGIHVRL
661 SGQDVERGTF SHRHHVLHDQ EVDRRTCVPM NHLWPDQAPY TVCNSSLSEY GVLGFELGYA
721 MASPNALVLW EAQFGDFHNT AQCIIDQFIS TGQAKWVRHN GIVLLLPHGM EGMGPEHSSA
781 RPERFLQMSN DDSDAYPAFT KDFEVSQLYD CNWIVVNCST PANYFHVLRR QILLPFRKPL
841 IIFTPKSLLR HPEAKSSFDQ MVSGTSFQRV IPEDGAAARA PEQVQRLIFC TGKVYYDLVK
901 ERSSQDLEEK VAITRLEQIS PFPFDLIKQE AEKYPGAELA WCQEEHKNMG YYDYISPRFM
961 TILRRARPIW YVGRDPAAAP ATGNRNTHLV SLKKFLDTAF NLQAFEGKTFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OGDHL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 120 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 120 nTPM
- kidney: 114 nTPM
- liver: 75 nTPM
- parathyroid gland: 47 nTPM
- cerebral cortex: 39 nTPM
- cerebellum: 38 nTPM
Single-cell type
- tuft cells: 161 nCPM
- epididymal clear cells: 147 nCPM
- renal collecting duct intercalated cells: 145 nCPM
- renal connecting tubule cells: 134 nCPM
- distal convoluted tubule cells: 130 nCPM
- proximal tubule cells: 93 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 215 nTPM
- cerebral cortex: 90 nTPM
- pons: 86 nTPM
- hypothalamus: 83 nTPM
- medulla oblongata: 78 nTPM
- thalamus: 76 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OGDHL.
Disease | AllUniProt
Conditions OGDHL is implicated in, by any mechanism.
- Yoon-Bellen neurodevelopmental syndrome (YOBELN) MIM:619701
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 253 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Yoon-Bellen neurodevelopmental syndrome
- Abnormal brain morphology
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.5
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- metal ion binding
- oxoglutarate dehydrogenase (succinyl-transferring) activity
- thiamine pyrophosphate binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dehydrogenase, E1 component
- Transketolase-like, pyrimidine-binding domain
- 2-oxoglutarate dehydrogenase E1 component
- Thiamin diphosphate-binding fold
- 2-oxoglutarate dehydrogenase E1 component/KDG, C-terminal
- 2-oxoglutarate dehydrogenase E1 component, N-terminal domain
- Multifunctional 2-oxoglutarate metabolism enzyme, C-terminal domain superfamily
- Dehydrogenase E1 component
- Transketolase, pyrimidine binding domain
- 2-oxoglutarate dehydrogenase N-terminus
- 2-oxoglutarate dehydrogenase C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OGDHL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OGDHL as an antibody target. Whether an autoantibody or antibody against OGDHL could matter depends on whether native OGDHL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OGDHL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OGDHL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...